SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : The Rational Analyst -- Ignore unavailable to you. Want to Upgrade?


To: HeyRainier who wrote (916)5/12/1998 6:12:00 PM
From: Scott H. Davis  Read Replies (3) | Respond to of 1720
 
[Larscom LARS response] LARS is a company that was overvalued when I started looking at them in 96 (I thought EQNX, PTIX and (speculatively) SBEI) were better values at the time. They were overvalued at 15 in early 97. But the market over reacted twice last year. It plunged in July when they met estimates but had nervous "forward looking comments". It oversold in late Dec again. Earnings are .07, .14 .14 -.56 and .09 last 5 qtrs. I can't find the Dec release, but the loss was mostly related to an acquisition. Absorbtion costs were a drain last qtr, but in the Apr. release, the coment was that the integration is proceeding on schedule. Over the past year they have been anouncing some interesting product development and contract wins releases. This is a case for rational analysis - TA alone would not necessairly show that they are recovering from an oversold condition. Looking at the research option under Zacks indicates that it has 1 strong buy and 4 buys, with a projected EPS growth rate of 47%. So combining the TA, FA and what I call "business case" (state of the business, products and its industry) are an important part of the analytical picture, for intermediate to long term holdings that is (I don't do short term trades)

So we have a business that is making progress (with some disappointments) in their business plan, has improving sales in areas of significant market growth, recovering from being oversold. Not to beat up on anybody, but not a good short candidate in my opinion.

My error is that I forgot to check back on LARS earlier - I missed an opportunity.

Note: I'm not recomending a LARS purchase for myself or anybody. I'm in the midst of a major biotech review for myself, and now for 2 frields recently diagnosed with cancer. But based on what I looked at today, this merits further review, especially if LARS retrenches back into the 9s. IMSCO Scott

Rainier, Dave or other TA heavyweights - from a TA perspective, what would a reasonable pullback target be?



To: HeyRainier who wrote (916)5/30/1998 12:25:00 PM
From: Greg Butcher  Respond to of 1720
 
RE:"YELL: A trend line breakout as of Friday's close. This was supposed to be on my watch list but I got lazy and didn't catch it. Your upper target is close to my own target of the upper Bollinger Band."

with summer here I think we should see this stock start to climb
soon. chart is looking better